April 29, 2022
The decision-makers who ruled on two government merger challenges recently highlighted the importance market definition plays in deciding cases, in delivering postmortems on the Justice Department's victory in its first arbitrated merger case and a rare Federal Trade Commission loss on a hospital deal. Law360 looks at some takeaways from a panel discussion.
March 01, 2021
The Federal Trade Commission has acknowledged its first loss of a hospital merger case in years by dropping its effort to stop the proposed $599 million tie-up of Philadelphia-area health care systems Jefferson Health and Albert Einstein Healthcare Network.
December 22, 2020
The Third Circuit has refused to issue an emergency block on the planned merger of Philadelphia-area health care systems Jefferson Health and Albert Einstein Healthcare Network as the Federal Trade Commission seeks to appeal a district court order rejecting its challenge to the tie-up.
December 14, 2020
The Federal Trade Commission has asked the Third Circuit to pause the planned tie-up between Philadelphia-area health care systems Jefferson Health and Albert Einstein Healthcare Network while it appeals to keep its merger challenge alive.
December 10, 2020
The Federal Trade Commission sought to stop two Philadelphia health care systems from completing their merger while the agency tries to reverse a court loss this week, saying, as a Pennsylvania federal judge acknowledged, it could soon be too late to "unscramble the egg."
December 08, 2020
A Pennsylvania federal court on Tuesday rejected a bid from the Federal Trade Commission and the state to block a $599 million merger between Philadelphia-area health care systems Jefferson Health and Albert Einstein Healthcare Network.
October 26, 2020
A Pennsylvania federal judge pressed Federal Trade Commission attorneys on Monday to explain why the government's market analysis should get court deference in an antitrust action seeking to block a $599 million merger of two Philadelphia-area hospital systems, pending a commission ruling.
September 29, 2020
A consultant for Thomas Jefferson Health's defense of its proposed $599 million merger with Albert Einstein Healthcare testified in Philadelphia Tuesday that a Federal Trade Commission analysis overstated the deal's market impact, wrongly triggering antitrust allegations.
September 15, 2020
A merger of two Philadelphia-area health systems could bump up some acute care hospital costs by 9% and inpatient rehab costs by as much as 20%, a government-commissioned economist testified Tuesday during the second day of a Federal Trade Commission injunction hearing.
September 14, 2020
Thomas Jefferson Health's finance chief conceded Monday during arguments over the Federal Trade Commission's bid to block a merger with Albert Einstein Healthcare that Jefferson had no evidence its partner was in danger of bankruptcy, despite painting Einstein's finances as "bleak" in earlier defenses of the deal.